Bendamustine in combination with rituximab (BR) for patients with relapsed chronic lymphocytic leukemia (CLL): A multicentre phase II trail of the German CLL Study Group (GCLLSG).

被引：6
|
作者：
Fischer, Kirsien [1 ]
Stilgenbauer, Stephan [2 ]
Schweighofer, Carmen D. [1 ]
Renschler, Jasmin [1 ]
Busch, Raymonde [3 ]
Kiehl, Michael [4 ]
Balleisen, Leopold [5 ]
Eckart, Michael [6 ]
Fink, Anna M. [1 ]
Boettcher, Sebastian [7 ]
Ritgen, Matthias [7 ]
Kneba, Michael [7 ]
Staib, Peter [1 ]
Doehner, Hartmut [2 ]
Eichhorst, Barbara F. [1 ]
Hallek, Michael [1 ]
机构：
[1] Univ Hosp, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp, Dept Internal Med, Ulm, Germany
[3] Tech Univ, Inst Med Stat & Epidemiol, Munich, Germany
[4] Hospital, Dept Internal Med, Frankfurt, Germany
[5] Hospital, Dept Internal Med, Hamm, Germany
[6] ISP Naegelsbacherstr, Erlangen, Germany
[7] Univ Hosp, Dept Internal Med, Kiel, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3106.3106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3106
引用
收藏
页码：913A / 914A
页数：2
相关论文
共 50 条
  • [31] Treatment of chronic lymphocytic Leukemia in over 80 Years: Experience of the German CLL Study Group (GCLLSG)
    Goede, V.
    Engelke, A.
    Busch, R.
    Hallek, M.
    INTERNIST, 2013, 54 : 127 - 127
  • [32] Obesity Negatively Impacts Outcome in Female Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR): An Analysis of Three Phase III Studies of the German CLL Study Group (GCLLSG)
    Fuerstenau, Moritz
    Hopfinger, Georg
    Robrecht, Sandra
    Fink, Anna-Maria
    Al-Sawaf, Othman
    Langerbeins, Petra
    Cramer, Paula
    Von Tresckow, Julia
    Maurer, Christian
    Kutsch, Nadine
    Hoechstetter, Manuela
    Dreyling, Martin
    Lange, Elisabeth
    Kneba, Michael
    Stilgenbauer, Stephan
    Doehner, Hartmut
    Hensel, Manfred
    Kiehl, Michael G.
    Jaeger, Ulrich
    Wendtner, Clemens-Martin
    Goede, Valentin
    Fischer, Kirsten
    Hallek, Michael
    Eichhorst, Barbara
    Theurich, Sebastian
    BLOOD, 2018, 132
  • [33] Targeted agents in chronic lymphocytic leukemia (CLL): data on outcomes and subsequent therapies of patients observed within the German CLL Study Group (GCLLSG) registry
    Kutsch, Nadine
    Ligtvoet, Rudy
    Robrecht, Sandra
    Linde, Hartmut
    Illmer, Thomas
    Doerfel, Steffen
    Lipke, Jorg
    Aldaout, Ali
    Schlag, Rudolf
    Dengler, Jolanta
    Al-Sawaf, Othman
    Langerbeins, Petra
    Cramer, Paula
    Eichhorst, Barbara
    Hallek, Michael
    Fischer, Kirsten
    Fink, Anna
    LEUKEMIA & LYMPHOMA, 2023, 64 : S125 - S126
  • [34] Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Garcia-Marco, Jose
    Tello, Patricia Baltasar
    Garcia, Esther Gonzalez
    Herranz, Eduardo Rios
    Payer, Angel Ramirez
    Castera, Maria Jose Terol
    Champ, Diana
    Perez, Angeles Medina
    Gironella, Mercedes
    Fernandez, Alicia Rodriguez
    Prat, Ana Muntanola
    Cabrera, Alexia Suarez
    Chacon, Manuel Jurado
    Zarzoso, Miguel Fernandez
    Rodriguez, Mercedes
    Clavel, Juana
    Sahun, Maria Victoria Dourdil
    Coll, Christelle M. Ferra
    Persona, Ernesto Perez
    Santos, Carmen Milagros Marrero
    Fores, Rafael
    Delgado, Julio
    BLOOD, 2017, 130
  • [35] Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    Cramer, P.
    Von Tresckow, J.
    Lange, E.
    Kiehl, M.
    Dreyling, M.
    Ritgen, M.
    Duerig, J.
    Tausch, E.
    Schneider, C.
    Stilgenbauer, S.
    Wendtner, C. M.
    Fischer, K.
    Goede, V
    Hallek, M.
    Eichhorst, B.
    LEUKEMIA, 2021, 35 (01) : 169 - 176
  • [36] First-line treatment and outcome in patients with chronic lymphocytic leukemia (CLL) according to age: a report of the German CLL Study Group (GCLLSG) registry
    Maurer, C.
    Fink, A. M.
    Robrecht, S.
    Bahlo, J.
    Fischer, K.
    Eichhorst, B.
    Hallek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 170 - 171
  • [37] Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Trial, International, Randomized Study Of The German CLL Study Group (GCLLSG)
    Eichhorst, Barbara
    Fink, Anna-Maria
    Busch, Raymonde
    Lange, Elisabeth
    Koeppler, Hubert
    Kiehl, Michael
    Soekler, Martin
    Schlag, Rudolf
    Vehling-Kaiser, Ursula
    Koechling, Georg
    Ploeger, Christoph
    Gregor, Michael
    Plesner, Torben
    Trneny, Marek
    Fischer, Kirsten
    Doehner, Hartmut
    Kneba, Michael
    Wendtner, Clemens
    Klapper, Wolfram
    Kreuzer, Karl-Anton
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Hallek, Michael
    BLOOD, 2013, 122 (21)
  • [38] Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    O. Al-Sawaf
    S. Robrecht
    J. Bahlo
    A. M. Fink
    P. Cramer
    J. v Tresckow
    E. Lange
    M. Kiehl
    M. Dreyling
    M. Ritgen
    J. Dürig
    E. Tausch
    C. Schneider
    S. Stilgenbauer
    C. M. Wendtner
    K. Fischer
    M. Goede
    B. Hallek
    Leukemia, 2021, 35 : 169 - 176
  • [39] Serum Factors Predict Therapeutic Outcome In Patients with Chronic Lymphocytic Leukemia Treated In the CLL8 Trial of the German CLL Study Group (GCLLSG)
    Fink, Anna
    Pflug, Natali
    Busch, Raymonde
    Fingerle-Rowson, Gunter R.
    Eichhorst, Barbara
    Wendtner, Clemens-Martin
    Winkler, Dirk
    Buehler, Andreas
    Mendila, Myriam
    Wenger, Michael
    Dohner, Hartmut
    Stilgenbauer, Stephan
    Hallek, Michael
    Fischer, Kirsten
    BLOOD, 2010, 116 (21) : 404 - 405
  • [40] Prospective evaluation of prognostic parameters in early stage chronic lymphocytic leukemia (CLL): Results of the CLL1-protocol of the German CLL study group (GCLLSG)
    Bergmann, Manuela A.
    Eichhorst, Barbara F.
    Busch, Raymonde
    Adorf, Dagmar
    Stilgenbauer, Stephan
    Eckart, Michael J.
    Wendtner, Clemens-Martin
    Hallek, Michael
    BLOOD, 2007, 110 (11) : 193A - 193A
12345